BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6351339)

  • 1. Coagulant and fibrinolytic activities in the leukemic cell lysates.
    Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
    Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
    Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen activator in leukemic cell homogenate].
    Wada H; Ogasawara Z; Kumeda Y; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T
    Rinsho Ketsueki; 1990 Nov; 31(11):1794-9. PubMed ID: 2287063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z; Chen X; Tan Y; Xu Z; Xu L
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tissue factor levels in leukemic cell homogenate.
    Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tissue thromboplastin in the development of DIC accompanying neoplastic diseases.
    Gonmori H; Maekawa T; Kobayashi N; Tanaka H; Tsukada H; Takada M; Andou K
    Bibl Haematol; 1983; (49):23-39. PubMed ID: 6667248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
    Ten Cate H; Leader A
    Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of normal and leukemic leukocytes on blood coagulation and fibrinolysis].
    Hiller E
    Fortschr Med; 1978 Jun; 96(22):1181-4. PubMed ID: 658868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin in disseminated intravascular coagulation.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1992 Oct; 41(2):71-5. PubMed ID: 1415185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical activities of lysosomal acid hydrolases in leukemic cells.
    Tanaka T; Kobayashi M; Saito O; Kamada N; Kuramoto A; Usui T
    Clin Chim Acta; 1981 Dec; 117(2):121-31. PubMed ID: 6946881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of tissue factor antigen and activity on the surface of leukemic cells.
    Tanaka M; Yamanishi H
    Leuk Res; 1993 Feb; 17(2):103-11. PubMed ID: 8429686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of tissue type plasminogen activator by leukaemic cell homogenates.
    Wada H; Kumeda Y; Ogasawara Z; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Kageyama S; Kobayashi T
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):591-7. PubMed ID: 8218856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity.
    Chorba TL; Orenstein JM; Ney AB; Schwartz BS; Alabaster O; Kessler CM; Cohen P; Schulof RS
    Cancer; 1985 Feb; 55(3):675-81. PubMed ID: 3880664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.
    Fibach E; Treves A; Korenberg A; Rachmilewitz EA
    Am J Hematol; 1985 Nov; 20(3):257-65. PubMed ID: 3904416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S; Meyerson H; Skallerud G; Rosenthal N
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.